Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The 1+Million Genomes Minimal Dataset for Cancer.
Riba M, Sala C, Culhane AC, Flobak Å, Patocs A, Boye K, Plevova K, Pospíšilová Š, Gandolfi G, Morelli MJ, Bucci G, Edsjö A, Lassen U, Al-Shahrour F, Lopez-Bigas N, Hovland R, Cuppen E, Valencia A, Poirel HA, Rosenquist R, Scollen S, Arenas Marquez J, Belien J, De Nicolo A, De Maria R, Torrents D, Tonon G. Riba M, et al. Among authors: de nicolo a. Nat Genet. 2024 May 3. doi: 10.1038/s41588-024-01721-x. Online ahead of print. Nat Genet. 2024. PMID: 38702538 No abstract available.
Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant.
Block I, Mateu-Regué À, Do TTN, Miceikaite I, Sdogati D, Larsen MJ, Hao Q, Nielsen HR, Boonen SE, Skytte AB, Jensen UB, Høffding LK, De Nicolo A, Viel A, Tudini E, Parsons MT, Hansen TVO, Rossing M, Kruse TA, Spurdle AB, Thomassen M. Block I, et al. Among authors: de nicolo a. Breast Cancer Res. 2024 Jan 9;26(1):6. doi: 10.1186/s13058-023-01755-9. Breast Cancer Res. 2024. PMID: 38195559 Free PMC article.
Pharmacokinetics of tecovirimat in subjects with Mpox.
Tempestilli M, Mondi A, D'Avolio A, Forini O, Pinnetti C, Mazzotta V, Gagliardini R, Beccacece A, De Nicolò A, Faccendini P, Cimini E, Maggi F, Girardi E, Nicastri E, Boffito M, Vaia F, Antinori A. Tempestilli M, et al. Among authors: de nicolo a. Int J Antimicrob Agents. 2024 Feb;63(2):107068. doi: 10.1016/j.ijantimicag.2023.107068. Epub 2023 Dec 22. Int J Antimicrob Agents. 2024. PMID: 38141836 Free article.
Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin.
Gausi K, Mugerwa H, Siccardi M, Montanha MC, Lamorde M, Wiesner L, D'Avolio A, McIlleron H, Wilkins E, De Nicolò A, Maartens G, Khoo S, Kityo C, Denti P, Waitt C. Gausi K, et al. Among authors: de nicolo a. Clin Infect Dis. 2023 Nov 20:ciad700. doi: 10.1093/cid/ciad700. Online ahead of print. Clin Infect Dis. 2023. PMID: 37982585 Free article.
Experimental pharmacology in precision medicine.
Urbaniak A, Thummel KE, Alade AN, Rettie AE, Prasad B, De Nicolò A, Martin JH, Sheppard DN, Jarvis MF. Urbaniak A, et al. Among authors: de nicolo a. Pharmacol Res Perspect. 2023 Dec;11(6):e01147. doi: 10.1002/prp2.1147. Pharmacol Res Perspect. 2023. PMID: 37885364 Free PMC article. No abstract available.
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting.
Venuti F, Gaviraghi A, De Nicolò A, Stroffolini G, Longo BM, Di Vincenzo A, Ranzani FA, Quaranta M, Romano F, Catellani E, Marchiaro C, Cinnirella G, D'Avolio A, Bonora S, Calcagno A. Venuti F, et al. Among authors: de nicolo a. Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214. Antibiotics (Basel). 2023. PMID: 37508309 Free PMC article.
154 results